Targets the Entire GI Tract
For a Healthy and Balanced Intestinal Ecology
Lyme disease is on the rise; more than 300,000 new cases are reported each year. In chronic Lyme disease and other neurological conditions, treatment is often more challenging, as pathogens can hide in the central nervous system, fatty tissues, or intracellularly and are often part of a biofilm matrix. In Lyme, not only are Borrelia burgdorferi spirochetes present, but other co-infections, such as Babesia, are also common.
We are very excited to be able to offer Liposomal delivery of our broad-spectrum Biocidin® combination as specialized nutritional support. Physicians’ reports of reduction in pain and other symptoms in as little as 4-6 weeks of use have been very encouraging.
- Assists in delivering broad-spectrum botanicals to the central nervous system, a key benefit as nutritional support in Lyme disease or other microbial challenges.*
- Promotes intracellular absorption of ingredients.*
- Enhances lymphatic circulation of therapeutic compounds.*
- Unilamellar Vesicles encapsulating Biocidin have an optimal particle size of 100 nanometers.
- Immediate bioavailability from the oral cavity.
- Assists in the removal of biofilms.*
- To decrease possible die-off or detoxification reactions, we always recommend concurrent usage of G.I. Detox™ with Biocidin®.
- Excellent support for oral health care, use with Dentalcidin™.
What are Liposomes?
Liposomes are microscopic single to multi-layer spheres made of phospholipids, the basic building blocks of cell membranes. Liposomes demonstrate the ability to cross the blood-brain barrier, deposit their cargo intracellularly, and enhance lymphatic circulation of therapeutic compounds.
Additionally, the phospholipids which compose the liposomes fuse with and feed cell membranes. Providing phospholipids in this way ensures proper membrane function to facilitate the absorption of nutrients and the excretion of cellular waste products and toxins. However, all liposomes are not created equally.
Many liposomes on the market use a low grade of phospholipid such as raw lecithin instead of the high phosphatidyl choline phospholipids necessary for therapeutic grade liposomes. Manufacturing processes of lower grade products also use less expensive shear methods, which results in large (200-600 nanometer), poorly absorbed particles.
Biocidin® provides 100 nanometer or smaller particle size optimal for therapeutic use.